Table 3. Analyses of covariances of levels of fasting metabolic parameters among three antipsychotic groups with different metabolic side effects.

Real values are given, but log transformation was performed before statistical analyses for data that were not normally distributed (Fasting plasma glucose, Triglyceride/HDL-cholesterol). The post-hoc analyses were performed using Bonferroni method. ^*data are adjusted for differences in age, sex, duration of current AAP and HPD-equivalent dosage of current AAP, ^†data are adjusted for differences in age, sex, BMI, duration of current AAP, and HPD-equivalent dosage of current AAP. CL: clozapine, OL: olanzapine, QT: quetiapine, RSP: risperidone, ARP: aripiprazole, ZPS: ziprasidone, BMI: body mass index, HDL: high-density lipoprotein, BP: blood pressure, AAP: atypical antipsychotic, HPD: haloperidol